

Imunorix oral solution - transparent liquid of red-violet color with a smell of wild berries.
1 vial contains pidotimod 400.0 mg;
Excipients: sodium chloride 5.6 mg, sodium saccharinate 5.0 mg, disodium edetate 3.5 mg, trometamol q.s. to pH 6.5, methyl parahydroxybenzoate sodium 10.3 mg, propyl parahydroxybenzoate sodium 1.6 mg, sorbitol 70% 2500 mg, fruit flavoring (with the smell of wild berries) 21.0 mg, anthocyanin dye 5.6 mg, dye crimson [Ponso 4R] 0.5 mg, purified water to 7.0 ml;
on 7 ml in a bottle, 10 single-dose bottles in a cardboard pack.
Imunorix is an immunostimulating agent.
Stimulates and regulates cellular and humoral immunity under immunodeficiency conditions. Effect on T-cell immunity - pidotimod enhances the activity of natural killer cells and activates phagocytosis. Effect on humoral immunity - pidotimod increases the production of cytokines.
Immunocorrection of bacterial, fungal and viral infections of the upper and lower respiratory and urinary tract, as part of complex therapy.
Hypersensitivity to any of the components of the drug, children's age up to 3 years, pregnancy and lactation.
Carefully:
should be used in patients with hyperimmunoglobulinemia E syndrome, with previously encountered allergic reactions
Adults: 800 mg pidotimod (2 bottles) twice a day out of meals for 15 days.
Children over 3 years: 400 mg pidotimod (1 bottle) twice a day out of meals for 15 days.
The dose and duration of the drug can be adjusted depending on the severity and severity of symptoms of the disease. Course duration not more than 90 days.
The daily dose for admission should not exceed 800 mg orally for children older than 3 years and, accordingly, 1600 mg orally for adults.
Allergic reactions.
Imunorix can affect the effectiveness of drugs that suppress or stimulate the functional activity of lymphocytes.
At a temperature not higher than 30 ° C.
Keep out of the reach of children!